SpineCraft, LLC, based in Westmont, Illinois, has launched a novel retractor for minimally invasive spine surgery (MIS). The PANORAMA has a patent-pending design and, according to the company, allows increased instrument angulation and versatility and expands the surgeon’s ability to access the entire disc space including difficult to reach contralateral locations.
SpineCraft Launches PANORAMA Retractor

According to the company, “PANORAMA opens the confines of a traditional cylindrical tube improving the efficiency and effectiveness intervertebral discectomy and endplate preparation for fusion and allows more controlled and precise implant positioning.”
Steve Mather, M.D., an orthopedic surgeon with DuPage Medical Group, said, “I began using the SpineCraft PANORAMA retractor for my minimally invasive TLIF [transforaminal lumbar interbody fusion] procedures and I have found that the retractor opening frees my instruments so I can now reach the entire disc space including difficult to access contralateral anatomy.”
“For years I had used a standard cylindrical tube that was confining and required tedious and time-consuming repositioning to adequately address the pathology and to properly prepare the disc space for the interbody implant. The addition of an opening in the PANORAMA retractor eliminates this problem and expands the functionality of an MIS retractor. This advancement has translated into a more efficient procedure, precise implant positioning and a reduction in surgery time.”
Wagdy Asaad, M.D, president and CEO of SpineCraft, told OTW, “Over the last couple of years SpineCraft has continued to expand its differentiated MIS product portfolio in collaboration with key MIS surgeons in the U.S. and internationally. I am proud of our R&D and Regulatory teams success in bringing these products to the market in record pace.”
“This new MIS access system, PANORAMA, expands the surgeon’s ability to access the entire disc space including difficult to reach contralateral locations. The innovative, patent-pending design significantly improves the efficiency and effectiveness of interbody fusion procedures and allows more controlled and precise implant positioning.”
“Looking ahead, we are in a period of clear acceleration in our innovation cycle and we expect to see several important new product launches over the next few quarters.”

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.